retifanlimab,pembrolizumab,Bria-IMT
Incyte,Merck,BriaCell Therapeutics
['breast']
$bctx briacell presents positive data demonstrating survival and clinical benefits in advanced metastatic breast cancer at the 2023 aacr 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities